Page last updated: 2024-09-05

lasofoxifene and Female Genitourinary Diseases

lasofoxifene has been researched along with Female Genitourinary Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, DF1

Other Studies

1 other study(ies) available for lasofoxifene and Female Genitourinary Diseases

ArticleYear
The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.
    Menopause (New York, N.Y.), 2011, Volume: 18, Issue:1

    Topics: Breast Neoplasms; Estrogen Antagonists; Estrogens; Female; Female Urogenital Diseases; Humans; Indoles; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes

2011